Abstract 1399: Tumor-specific molecular changes in luminal B breast cancer patient-derived xenografts (PDXs) with acquired resistance to endocrine treatment by De Boisferon, Marc Hillairet, Benzaid, Ismahène, Chatel, Elodie Marie Dit, Hoffmann, Nicolas, Littlefield, Bruce A.

Get full text

Abstract 1659: Development of an orthotopic murine model of a patient-derived pancreatic adenocarcinoma to evaluate the tissue specificity of two novel fluorescent compounds by Duchamp, Olivier, Berthet, Cyril, Provent, Peggy, Chatel, Elodie Marie Dit, Longin, Jordan, Urbain, Stanislas, Scherninski, François

Get full text

Abstract 5281: Development of a panel of breast cancer patient-derived xenograft models (PDX) with estrogen independence and/or acquired resistance to endocrine treatment by de Boisferon, Marc Hillairet, Benzaid, Ismahene, Chatel, Elodie Marie Dit, Hoffmann, Nicolas, Littlefield, Bruce

Get full text

Abstract 4719: Synergistic anticancer activity of triple combinations of eribulin, palbociclib and fulvestrant in hormone dependent patient-derived xenograft (PDX) models of human... by Boisferon, Marc Hillairet de, Chatel, Elodie Marie Dit, Nomoto, Kenichi, Littlefield, Bruce A.

Get full text

Abstract 5044: Antitumor activity comparison of two somatostatin receptor ligands radiolabeled with Lutetium-177 (SSO110 and DOTA-TATE) alone or combined with chemotherapy in mice... by Raguin, Olivier, Krüger, Marcel, Provent, Peggy, Cay, Funda, Marie dit chatel, Elodie, Lux, Marie, Lezmi, Stéphane, Meyer-Losic, Florence, Plas, Pascale, Pais, Ben, Berthet, Cyril

Get full text